These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 30055803)
1. Autophagy is involved in acetylshikonin ameliorating non-alcoholic steatohepatitis through AMPK/mTOR pathway. Zeng J; Zhu B; Su M Biochem Biophys Res Commun; 2018 Sep; 503(3):1645-1650. PubMed ID: 30055803 [TBL] [Abstract][Full Text] [Related]
2. Alisol A 24-acetate ameliorates nonalcoholic steatohepatitis by inhibiting oxidative stress and stimulating autophagy through the AMPK/mTOR pathway. Wu C; Jing M; Yang L; Jin L; Ding Y; Lu J; Cao Q; Jiang Y Chem Biol Interact; 2018 Aug; 291():111-119. PubMed ID: 29883724 [TBL] [Abstract][Full Text] [Related]
3. Resveratrol ameliorates hepatic steatosis and inflammation in methionine/choline-deficient diet-induced steatohepatitis through regulating autophagy. Ji G; Wang Y; Deng Y; Li X; Jiang Z Lipids Health Dis; 2015 Oct; 14():134. PubMed ID: 26498332 [TBL] [Abstract][Full Text] [Related]
4. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway. He Q; Sha S; Sun L; Zhang J; Dong M Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776 [TBL] [Abstract][Full Text] [Related]
5. Antagonizing circRNA_002581-miR-122-CPEB1 axis alleviates NASH through restoring PTEN-AMPK-mTOR pathway regulated autophagy. Jin X; Gao J; Zheng R; Yu M; Ren Y; Yan T; Huang Y; Li Y Cell Death Dis; 2020 Feb; 11(2):123. PubMed ID: 32054840 [TBL] [Abstract][Full Text] [Related]
6. Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages. Liu B; Deng X; Jiang Q; Li G; Zhang J; Zhang N; Xin S; Xu K Biomed Pharmacother; 2020 May; 125():109895. PubMed ID: 32000066 [TBL] [Abstract][Full Text] [Related]
7. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice. Zhang J; Zhang H; Deng X; Zhang N; Liu B; Xin S; Li G; Xu K Life Sci; 2018 Jan; 192():46-54. PubMed ID: 29158052 [TBL] [Abstract][Full Text] [Related]
8. Protective role of autophagy in methionine-choline deficient diet-induced advanced nonalcoholic steatohepatitis in mice. Chen R; Wang Q; Song S; Liu F; He B; Gao X Eur J Pharmacol; 2016 Jan; 770():126-33. PubMed ID: 26593434 [TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet. Ding Y; Sun X; Chen Y; Deng Y; Qian K Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348 [TBL] [Abstract][Full Text] [Related]
10. Betaine modulates oxidative stress, inflammation, apoptosis, autophagy, and Akt/mTOR signaling in methionine-choline deficiency-induced fatty liver disease. Veskovic M; Mladenovic D; Milenkovic M; Tosic J; Borozan S; Gopcevic K; Labudovic-Borovic M; Dragutinovic V; Vucevic D; Jorgacevic B; Isakovic A; Trajkovic V; Radosavljevic T Eur J Pharmacol; 2019 Apr; 848():39-48. PubMed ID: 30689995 [TBL] [Abstract][Full Text] [Related]
11. Gemigliptin, a DPP4 inhibitor, ameliorates nonalcoholic steatohepatitis through AMP-activated protein kinase-independent and ULK1-mediated autophagy. Song Y; Yang H; Kim J; Lee Y; Kim SH; Do IG; Park CY Mol Metab; 2023 Dec; 78():101806. PubMed ID: 37739179 [TBL] [Abstract][Full Text] [Related]
12. Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress. Qiang X; Xu L; Zhang M; Zhang P; Wang Y; Wang Y; Zhao Z; Chen H; Liu X; Zhang Y Biochem Biophys Res Commun; 2016 Apr; 472(4):603-9. PubMed ID: 26970305 [TBL] [Abstract][Full Text] [Related]
13. Neuregulin 4 alleviates hepatic steatosis via activating AMPK/mTOR-mediated autophagy in aged mice fed a high fat diet. Zhu B; Mei W; Jiao T; Yang S; Xu X; Yu H; Ding Y; Guo S; Meng B; Zhao L; He M; Dong K; Guo H; Guo X; Zhang H; Dang R; Xiang G; Wen N Eur J Pharmacol; 2020 Oct; 884():173350. PubMed ID: 32726654 [TBL] [Abstract][Full Text] [Related]
14. Terf2ip deficiency accelerates non-alcoholic steatohepatitis through regulating lipophagy and fatty acid oxidation via Sirt1/AMPK pathway. Wang Y; Liu S; Ni M; Chen Y; Chen R; Wang J; Jiang W; Zhou T; Fan S; Chang J; Xu X; Zhang Y; Yu Y; Li X; Li C Free Radic Biol Med; 2024 Aug; 220():78-91. PubMed ID: 38697492 [TBL] [Abstract][Full Text] [Related]
15. Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition. Kim SH; Kim G; Han DH; Lee M; Kim I; Kim B; Kim KH; Song YM; Yoo JE; Wang HJ; Bae SH; Lee YH; Lee BW; Kang ES; Cha BS; Lee MS Autophagy; 2017 Oct; 13(10):1767-1781. PubMed ID: 28933629 [TBL] [Abstract][Full Text] [Related]
16. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis. Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173 [TBL] [Abstract][Full Text] [Related]
17. Over-expressing the soluble gp130-Fc does not ameliorate methionine and choline deficient diet-induced non alcoholic steatohepatitis in mice. Kammoun HL; Allen TL; Henstridge DC; Kraakman MJ; Peijs L; Rose-John S; Febbraio MA PLoS One; 2017; 12(6):e0179099. PubMed ID: 28632778 [TBL] [Abstract][Full Text] [Related]
18. CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy. Zhang X; Han J; Man K; Li X; Du J; Chu ES; Go MY; Sung JJ; Yu J J Hepatol; 2016 Jan; 64(1):160-70. PubMed ID: 26394162 [TBL] [Abstract][Full Text] [Related]
19. Hydrogen sulfide reduces serum triglyceride by activating liver autophagy via the AMPK-mTOR pathway. Sun L; Zhang S; Yu C; Pan Z; Liu Y; Zhao J; Wang X; Yun F; Zhao H; Yan S; Yuan Y; Wang D; Ding X; Liu G; Li W; Zhao X; Liu Z; Li Y Am J Physiol Endocrinol Metab; 2015 Dec; 309(11):E925-35. PubMed ID: 26442880 [TBL] [Abstract][Full Text] [Related]
20. Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis. Huang R; Guo F; Li Y; Liang Y; Li G; Fu P; Ma L Phytomedicine; 2021 Nov; 92():153739. PubMed ID: 34592488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]